Clinical Trials Directory

Trials / Completed

CompletedNCT01192802

Efficacy of Albendazole to Treat Intestinal Helminths and Its Effect on Gut Microflora

Effect of Intestinal Helminths on Gut Microflora

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Albert Schweitzer Hospital · Academic / Other
Sex
All
Age
4 Years – 14 Years
Healthy volunteers
Accepted

Summary

Albendazole is a main anti-helminth, however there is a lack of data regarding its efficacy in the school children population. The aim of this study is to evaluate the efficacy of the albendazole one versus two and three doses, in school children infected with intestinal helminth.

Conditions

Interventions

TypeNameDescription
DRUGalbendazole1 tablet of 400 mg of albendazole per day for three consecutive days
DRUGalbendazolesingle 1 tablet of 400 mg of albendazole
DRUGalbendazole1 tablet of 400 mg of albendazole per day for two consecutive days

Timeline

Start date
2010-08-01
Primary completion
2012-07-01
Completion
2012-07-01
First posted
2010-09-01
Last updated
2013-01-24

Locations

1 site across 1 country: Gabon

Source: ClinicalTrials.gov record NCT01192802. Inclusion in this directory is not an endorsement.